Post-transplant diabetes mellitus (PTDM) compromises long-term survival in liver transplant (LT) recipients. The aim of this study was to determine incidence of PTDM after LT and risk factors associated with it. A literature search was conducted, and prospective studies that reported on the incidence of PTDM in LT adult patients on tacrolimus, sirolimus, or cyclosporine were included. We performed random effects meta-analyses for the incidence of PTDM stratified by immunosuppressant and time period. Of 9817 articles identified, 26 studies were included in the qualitative analysis and 21 studies were eligible for the quantitative analysis representing 79 559 LT recipients in 32 separate treatment arms. The proportion of patients who developed PTDM by two-three years was 0.15 (95% CI: 0.10-0.24) for cyclosporine, 0.23 (95% CI: 0.14-0.36) for tacrolimus, and 0.27 (95% CI: 0.23-0.30) for sirolimus. CONCLUSION: Our results showed that sirolimus-based immunosuppression was associated with a higher incidence of PTDM than tacrolimus or cyclosporine at two-three years. However, there were only two studies that compared all three drugs which is a limitation of the study and requires more studies with patients on sirolimus. Recipient factors increasing the risk of PTDM are older age, male sex, and high BMI.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ctr.14340 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
"Effect of post-kidney transplant diabetes mellitus on long-term outcomes in a cohort of pediatric kidney transplant recipients from 2005 to 2022." Survival analysis.
BMJ Paediatr Open
December 2024
Pediatric Department, University of Antioquia, Medellin, Colombia.
Background: Post-transplantation diabetes mellitus and carbohydrate intolerance (PTDM/iCHO) are complications following solid organ transplantation, which significantly increases the risk of graft loss and mortality. However, data concerning long-term outcomes in paediatric kidney transplant recipients with PTDM/iCHO are scarce. This study aimed to evaluate the risk of graft loss in paediatric kidney transplant recipients with PTDM or iCHO compared with non-PTDM/iCHO.
View Article and Find Full Text PDFDevelopment of posttransplant diabetes mellitus in US recipients of liver transplant is influenced by OPTN region.
Liver Transpl
October 2024
Department of Epidemiology and Biostatistics, CUNY Graduate School of Public Health and Health Policy, New York, New York, USA.
Posttransplant diabetes mellitus (PTDM) is associated with significant morbidity and mortality in liver transplant recipients (LTRs). We used the Organ Procurement and Transplantation Network (OPTN) database to compare the incidence of developing PTDM across the United States and develop a risk prediction model for new-onset PTDM using OPTN region as well as donor-related, recipient-related, and transplant-related factors. All US adult, primary, deceased donor, LTRs between January 1, 2007, and December 31, 2016, with no prior history of diabetes noted, were identified.
View Article and Find Full Text PDFInfluence of gut flora on diabetes management after kidney transplantation.
BMC Nephrol
December 2024
Department of Organ Transplantation, Affiliated Hospital of Guizhou Medical University, No. 28 Guimedical Street, Yunyan District, Guiyang, Guizhou Province, 550000, China.
Post-transplant diabetes mellitus (PTDM) is a common complication following renal transplantation, and its incidence has been gradually increasing in recent years, posing a significant public health challenge. Managing PTDM is complex, as studies suggest that it involves changes in the microbial flora across multiple organs. Recent research highlights the critical role of gut flora metabolism in the development of diabetes among post-renal transplant patients.
View Article and Find Full Text PDFHbA1c changes in the first year post-kidney transplant and associated risk factors in a Saudi cohort.
Ther Adv Endocrinol Metab
November 2024
College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Article Synopsis
- - The study investigates changes in glycosylated hemoglobin (HbA1c) levels and the risk of post-transplant diabetes mellitus (PTDM) in kidney transplant recipients within the first year, focusing on demographic and health factors.
- - Results show that 64.04% of the 203 kidney transplant recipients experienced clinically significant HbA1c changes, with pre-transplant diabetes patients showing the most notable increases; PTDM developed in 15.7% of nondiabetics.
- - Key risk factors for significant HbA1c changes included increased age, weight change, and pre-existing hypertension, while PTDM was linked to older age and higher HbA1c levels at various checkpoints post-transplant
Hypothalamic-Pituitary-Adrenal Axis Activity and Metabolic Disorders in Kidney Transplant Recipients on Long-Term Glucocorticoid Therapy.
J Clin Med
November 2024
Department of Nephrology and Renal Transplantation, Medical School, National and Kapodistrian University of Athens, Laiko Hospital, 11527 Athens, Greece.
Article Synopsis
- The study investigates how common hypothalamic-pituitary-adrenal (HPA) axis suppression is among kidney transplant recipients (KTRs) on low doses of glucocorticoids, highlighting that 27.5% had low cortisol levels.* -
- It found that KTRs with low cortisol levels tended to be older and longer post-transplant, with cortisol levels positively correlating with other hormones like ACTH and DHEAS.* -
- Despite increased HPA axis suppression in these patients, the study concluded that it was not linked to metabolic disorders like hypertension or diabetes, suggesting ACTH could be a useful biomarker for monitoring HPA activity.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!